CH 19 FOOD-DRUG INTERACTIONS

1. CH 19 FOOD-DRUG INTERACTIONS Food-drug interactions can - Alter the intended response to the medication • Cause drug toxicity • Alter the normal nutritional status.

2. I. Pharmacologic Aspects of Food-Drug Interactions Two types: 1. Pharmacodynamic interactions - affect the pharmacologic action of the drug 2. Pharmacokinetic interactions - affect the movement of the drug into, around, or out of the body

3. 1. Pharmacodynamics: - Studying the biochemical and physiologic effects of a drug - Mechanism of action of a drug: binding of the drug mol. to receptor, enzyme, or ion channel→ physiologic response. *Agonist: Enhance normal metabolism and physiologic function *Antagonist: Attenuate normal metabolism and physiologic function

4. 2. Pharmacokinetics – the study of the time course of a drug in the body, including absorption , distribution, metabolism (biotransformation), excretion. (1) Absorption – from the adm. Site to blood stream a. route of administration iv: intravenous im: intramuscular ip: intraperitoneal Sc: subcutaneous b. the chemistry of the drug and its ability to cross biologic membranes c. the rate of gastric emptying and GI movement d. the quality of the product formulation.

5. (2) Distribution – drug leaves the systemic circulation and travels to various regions of the body, - the drug’s chemistry and ability to cross biologic membranes. - the rate and extent of blood flow - bound form or unbound fraction

6. (3) Biotransformation (metabolism) of drugs: major in the liver. - cytochrome P-450 enzyme system (Fig 12-2, p311), substances ↑or↓ this enzyme system may change the rate or extent of drug metabolism.

7. (4) Excretion: - Renal excretion: Glomerular filtration or tubular secretion Ex. Urinary pH – affect tubular re-absorption - Bile or other body fluid, lesser extent.

8. II. Risk factors for Drug-Nutrient Interactions 1. Drug-induced malnutrition – most commonly during long-term treatment for chronic disease 2. Existing malnutrition places people at risk for drug-nutrient interactions 3. Specific nutrient deficiencies can affect drug metabolism by influencing the MFOS 4. Body composition - drug response

9. Pharmacogenomics – Genetically determined variations that are revealed solely by the effects of drugs. Ex.(1) Slow acetylators: lower levels of the hepatic enzyme acetyl transferase → (a) INH (isoniazid) user: ↑risk of pyridoxine def. (b) phenelzine (MAO inhibitor) user: ↑risk of HTN if ingest foods high in tyramine (Box 19-2) (2) G6PD deficiency: X-chromosome-linked def. of G6PD in RBC - Fava beans or pollen can cause acute hemolysis

10. III. EFFECT OF FOOD ON DRUG THERAPY • Effect on Drug Absorption: The presence of food and nutrients in the stomach or GI lumen →↓drug abs. Ex.: abs. of Fe may be ↓50% when taken with food

11. - Mechanisms • Rate of the gastric empty • Chelation – drugs and divalent or trivalent cations • Adsorption • GI pH

12. 2. Medication and Enteral Nutrition Interactions • Liquid medication mixed with enteral feeding formulas (1) cause granulation and gel formation (2) Emulsion breakage

13. 3. Drug Distribution low serum Alb. →↑unbound fraction drug→↑risk for adverse effects from highly protein-bound drugs Ex.: Anticoagulant - warfarin, anticonvulsant - phenytoin

14. 4. Effect on Drug Metabolism - Enzymes in GI & liver – account for a large portion of the drug meta. (1) Hi-protein, Lo-CHO diet →↑the hepatic metabolism of theophylline (antiasthma drug) (2) Substance found in grapefruit can inhibit the intestinal metabolism of drugs →↑drug in the circulation →↑toxicity. (3) Competition between food and drugs with hepatic enzymes →↑drug in the circulation →↑toxicity

15. 5. Effect on Drug Excretion • Food and drugs can alter the re-absorption of drugs from the renal tubule • Low Na intake or dehydration→↓Na re-absorption, →↓Li re-absorption. • Urinary pH changed →change the amount of drug existing in the nonionic state →↓drug re-absorption,

16. IV. Effects of Drugs on Food and Nutrition 1. Nutrient absorption (Appendix 34) • Chelation: tetracycline – Ca (or other divalent or trivalent ions) • Adsorption: Cholestyramine – fat soluble vitamins • Hi Mineral oil →↓fat soluble vitamins

17. (4) Influencing the transit time in the gut. Ex.: cathartic agents and laxatives (5) Changing GI environment. (pH) Ex.- Cimetidine→ ↓ HCl secretion & Intrinsic factor→ ↓Vit. B-12 abs. - Antacids: ↑pH & chelating minerals, ∴ ↓Ca, Fe, Mg & Zn abs. (6) Damage the intestinal mucosa. Ex.: chemotherapeutic agents, NSAIDS, long-term antibiotic therapy. (7) Affect intestinal transport mech.

18. 2. Nutrient Metabolism – • Drugs →↓or ↑nutrient metabolism Ex.: • phenobarbital and phenytoin (anticonvulsants) → ↑Vit. D, K and folic acid meta. • INH (anti-tuberculosis): blocks the conversion of pyridoxine → PLP • MTX: a folic acid antagonist →↓folate to be active form →megaloblastic anemia

19. 3. Nutrient Excretion • Interfering with nutrient re-absorption a. Diuretics (furosemide, ethacrynic acid, triamterene) →↑excretion of Ca, K, Mg, Zn etc. thiazide: →↑excretion of Na b. Chemotheraputic agents → hypomagnesemia

20. V. MODIFICATION OF DRUG ACTION BY FOOD AND NUTRIENTS 1. Substances enhance drug effects • MAOI and pressor agents (Box 19-2) * Biologically active amines a. the psychoactive amines (neuotransmitters) – norepinephrine and dopamine b. the vasoactive amines – tyramine, serotonin & histamine monoamine & diamine oxidase Amines→ → → → → → → deamination

21. Presence of the unoxidized pressor amines causes constriction of blood vessels and HTN→ Symptoms (2) Caffeine - ↑the adverse effects of stimulant drugs (3) Warfarin ( an oral anticoagulant) → ↓hepatic production of 4 vit. K-dependent clotting factors. *Dong Quai- contains coumarin-like substance *Ginseng - contains a platelet inhibitor.

22. 2. Alcohol (1) ethanol combined with CNS-depressant→ excessive drowsiness, incoordination and other signs of CNS depression (2) Mucosal irritant – with aspirin or other NSAIDs→↑risk of GI ulceration (3) →↑risk of hepatic toxicity (4) Inhibit gluconeogenesis, →↑prolong a hypoglycemic episode (5) ethanol+disulfiram →↑risk of life-threatening reaction

23. VI. Effects of drugs on Nutritional Status Drugs • Oral, Taste, and Smell (Box 19-3) - ↓Food intake (1) alteration in taste sensation (dysgeusia) (2) ↓taste sensation (hypogeusia) (3) an unpleasant aftertaste * Mechanisms? - alter the turnover of taste cells - interfere with transduction mech. - Alter neurotransmitters in the CNS

24. (4) Inflammation of the mucous membranes (mucositis) - Stomatitis (mouth inflammation) - glossitis (tongue inflammation) - Cheilitis (lip inflammation and cracking) (5)↓secretions → dry mouth→ dental caries and loss of teeth, gum disease, stomatitis and glossitis.

25. 2. Gastrointestinal Effects • GI irritation and ulceration – NSAIDs • Severe nausea and vomiting – Antineoplastic drugs → nausea nd vomiting • Changes in bowel function → constipation or diarrhea (↓peristalsis) • Destruction of intestinal bacteria (Box 19-6) • Inhibit intestinal enzymes – DM drugs →undigested CHO →diarrhea, flatulence, cramping etc.

26. 3. Appetite Changes • Suppress appetite (Box 19-7)→wt. changes, nutritional imbalance, and growth retardation in kids. - Side effects of stimulant drugs a. HTN b. interfere with the ability or desire to eat (2) Stimulate appetite (Box 19-8) )→wt. gains

27. 4. Organ System Toxicity - hepatotoxicity, nephrotoxicity, pulmonary toxicity, neurotoxicity, ototoxicity, ocular toxicity, pancreatitis, cardiotoxicity etc. Ex. Hepatotoxicity→ hepatitis, jaudice, hepatomegaly, liver failure etc.

28. 5. Glucose levels - Hypoglycemia or hyperglycemia (Box 19-9)

29. VII. EXCIPIENTS AND FOOD-DRUG INTERACTIONS - An excipients ( inactive ingredients) is added to drug formulations for its action as a buffer, binder, filler, diluent, disintegrate, glidant, flavoring, dye, preservative, suspending agent, or coating.

30. VIII. MEDICAL NUTRITION THERAPY (MNT) • Prospective – All MNT offered when the pt. first starts a drug • Retrospective – evaluation of symptoms to determine whether medical problems might be the result of food-drug interactions.